Profil
Eric Feller currently works at Société de Gestion de Projets et de Valorisation SA, as Director from 2012 and Targetome NV, as Managing Director & Director from 2010.
Postes actifs de Eric Feller
| Sociétés | Poste | Début |
|---|---|---|
Société de Gestion de Projets et de Valorisation SA
 Société de Gestion de Projets et de Valorisation SA Miscellaneous Commercial ServicesCommercial Services Société de Gestion de Projets et de Valorisation SA operates as a holding company with interests in providing agricultural technology and equipment. It offers scientific technology services in the field of electricity transmission and monitoring of power lines. The company is headquartered in Gembloux, Belgium | Directeur/Membre du Conseil | 29/05/2012 |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Directeur Général | 05/07/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Société de Gestion de Projets et de Valorisation SA
Société de Gestion de Projets et de Valorisation SA Miscellaneous Commercial ServicesCommercial Services Société de Gestion de Projets et de Valorisation SA operates as a holding company with interests in providing agricultural technology and equipment. It offers scientific technology services in the field of electricity transmission and monitoring of power lines. The company is headquartered in Gembloux, Belgium | Commercial Services |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Health Technology |
